Literature DB >> 20639008

Refining the definition of hypereosinophilic syndrome.

Hans-Uwe Simon1, Marc E Rothenberg, Bruce S Bochner, Peter F Weller, Andrew J Wardlaw, Michael E Wechsler, Lanny J Rosenwasser, Florence Roufosse, Gerald J Gleich, Amy D Klion.   

Abstract

Because of advances in our understanding of the hypereosinophilic syndrome (HES) and the availability of novel therapeutic agents, the original criteria defining these disorders are becoming increasingly problematic. Here, we discuss shortcomings with the current definition of HES and recent developments in the classification of these disorders. Despite significant progress in our understanding of the pathogenesis of some forms of HES, the current state of knowledge is still insufficient to formulate a new comprehensive etiologic definition of HESs. Nevertheless, we suggest a new working definition that overcomes some of the most obvious limitations with the original definition.

Entities:  

Mesh:

Year:  2010        PMID: 20639008      PMCID: PMC3400024          DOI: 10.1016/j.jaci.2010.03.042

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  23 in total

Review 1.  Practical approach to the patient with hypereosinophilia.

Authors:  Florence Roufosse; Peter F Weller
Journal:  J Allergy Clin Immunol       Date:  2010-06-09       Impact factor: 10.793

2.  Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis.

Authors:  Sabine-Gisela Plötz; Hans-Uwe Simon; Ulf Darsow; Dagmar Simon; Ekatherina Vassina; Shida Yousefi; Rüdiger Hein; Tim Smith; Heidrun Behrendt; Johannes Ring
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

3.  Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report.

Authors:  Amy D Klion; Bruce S Bochner; Gerald J Gleich; Thomas B Nutman; Marc E Rothenberg; Hans-Uwe Simon; Michael E Wechsler; Peter F Weller
Journal:  J Allergy Clin Immunol       Date:  2006-05-03       Impact factor: 10.793

4.  cIAP-2 and survivin contribute to cytokine-mediated delayed eosinophil apoptosis.

Authors:  Ekatherina M Vassina; Shida Yousefi; Dagmar Simon; Caroline Zwicky; Sébastien Conus; Hans-Uwe Simon
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

Review 5.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

6.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

7.  Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome.

Authors:  F Roufosse; L Schandené; C Sibille; K Willard-Gallo; B Kennes; A Efira; M Goldman; E Cogan
Journal:  Br J Haematol       Date:  2000-06       Impact factor: 6.998

8.  Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia.

Authors:  H U Simon; S G Plötz; R Dummer; K Blaser
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

9.  High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome.

Authors:  Aurore de Lavareille; Florence Roufosse; Peter Schmid-Grendelmeier; Anne-Sophie Roumier; L Schandené; Elie Cogan; Hans-Uwe Simon; Michel Goldman
Journal:  J Allergy Clin Immunol       Date:  2002-09       Impact factor: 10.793

Review 10.  The hypereosinophilic syndrome revisited.

Authors:  Florence Roufosse; Elie Cogan; Michel Goldman
Journal:  Annu Rev Med       Date:  2001-12-03       Impact factor: 13.739

View more
  82 in total

Review 1.  Practical approach to the patient with hypereosinophilia.

Authors:  Florence Roufosse; Peter F Weller
Journal:  J Allergy Clin Immunol       Date:  2010-06-09       Impact factor: 10.793

Review 2.  Eosinophilic myeloproliferative disorders.

Authors:  Amy D Klion
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

3.  Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome.

Authors:  P Khoury; P Zagallo; C Talar-Williams; C S Santos; E Dinerman; N C Holland; A D Klion
Journal:  Allergy       Date:  2012-07-09       Impact factor: 13.146

Review 4.  Hypereosinophilic syndrome: approach to treatment in the era of precision medicine.

Authors:  Amy Klion
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

5.  Response of Complex Undefined Hypereosinophilic Syndrome to Treatment with Imatinib.

Authors:  İnsu Yılmaz; Leylagül Kaynar; Nuri Tutar; Çiğdem Pala; Özlem Canöz; Afra Yıldırım; Hakan Büyükoğlan; İnci Gülmez
Journal:  Turk Thorac J       Date:  2016-07-01

Review 6.  Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.

Authors:  Zhaleh J Amini-Vaughan; Margarita Martinez-Moczygemba; David P Huston
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

Review 7.  Therapeutic approaches to patients with hypereosinophilic syndromes.

Authors:  Hans-Uwe Simon; Amy Klion
Journal:  Semin Hematol       Date:  2012-04       Impact factor: 3.851

8.  Unravelling the NERDS syndrome.

Authors:  Achintya Dinesh Singh; Tejas Menon Suri; Rakesh Kumar Jagdish; Uma Kumar
Journal:  BMJ Case Rep       Date:  2018-05-12

9.  Eosinophilic gastroenteritis and related eosinophilic disorders.

Authors:  Calman Prussin
Journal:  Gastroenterol Clin North Am       Date:  2014-06       Impact factor: 3.806

10.  Hypereosinophilia-an unusual cause of multiple embolic strokes and multi-organ dysfunction.

Authors:  Geeta A Khwaja; Ashish Duggal; Amit Kulkarni; Neera Choudhary; Meena Gupta; Debashish Chowdhury; Vikram Bohra; Dhruv Zutshi
Journal:  J Clin Diagn Res       Date:  2013-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.